Smithfield Trust’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-70
Closed -$6K 1102
2021
Q4
$6K Hold
70
﹤0.01% 981
2021
Q3
$6K Hold
70
﹤0.01% 992
2021
Q2
$5K Sell
70
-75
-52% -$5.46K ﹤0.01% 990
2021
Q1
$10K Hold
145
﹤0.01% 856
2020
Q4
$10K Hold
145
﹤0.01% 823
2020
Q3
$10K Buy
145
+70
+93% +$5.49K ﹤0.01% 783
2020
Q2
$5K Buy
+75
New +$5.34K ﹤0.01% 863
2019
Q1
Sell
-2,085
Closed -$110K 964
2018
Q4
$110K Sell
2,085
-139
-6% -$7.94K 0.01% 336
2018
Q3
$141K Sell
2,224
-14
-0.6% -$906 0.02% 337
2018
Q2
$131K Buy
2,238
+21
+0.9% +$1.14K 0.02% 345
2018
Q1
$114K Sell
2,217
-20
-0.9% -$1.07K 0.01% 378
2017
Q4
$133K Buy
2,237
+54
+2% +$3.27K 0.02% 357
2017
Q3
$129K Buy
2,183
+490
+29% +$29.2K 0.02% 355
2017
Q2
$95K Buy
+1,693
New +$93.6K 0.01% 419

Other funds holding CONE

Smithfield Trust's CONE Position: Q1 2022 in Review

Smithfield Trust sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 70 shares — an estimated $6K sold.

Smithfield Trust first reported a position in CONE in Q2 2017 and held it in 14 quarters. The position peaked at $141K in Q3 2018. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Smithfield Trust reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Smithfield Trust sold 70 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $6K.
  • Smithfield Trust first reported a position in CyrusOne Inc Common Stock in Q2 2017 and held it in 14 quarters.
  • Smithfield Trust's CyrusOne Inc Common Stock position peaked at $141K in Q3 2018.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Smithfield Trust's 13F filing for Q1 2022, filed 16 May 2022.